C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 413/04 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2507100
Compounds having formula I are provided where the variables have the values described herein. (I). Pharmaceutical formulations include the compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier and combinations with other agents. A method of treating a patient comprises administering a pharmaceutical formulation according to the invention to a patient in need thereof.
Cette invention se rapporte à des composés de formule (I), dans laquelle les variables ont les valeurs décrites dans les pièces descriptives de la demande. Cette invention concerne en outre des formulations pharmaceutiques contenant ces composés ou des sels pharmaceutiquement acceptables de ces composés et un excipient pharmaceutiquement acceptable et des combinaisons avec d'autres agents. Cette invention concerne également un procédé de traitement consistant à administrer une telle formulation pharmaceutique à un patient nécessitant un tel traitement.
Nuss John M.
Pecchi Sabina
Renhowe Paul A.
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
2,4,6-trisubstituted pyrimidines as phosphotidylinositol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4,6-trisubstituted pyrimidines as phosphotidylinositol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4,6-trisubstituted pyrimidines as phosphotidylinositol... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1369799